Quanterix Corporation Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Quanterix Corporation (QTRX) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $38.75 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2026-08-10
- 2026-06-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $38.75M.
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $33.14M.
- 2025-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $20.21M.
- 2025-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $22.90M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months |
|---|---|
| 2026-06-30 | $38.75M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $33.14M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $20.21M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $22.90M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $62.29M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $93.38M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $74.65M 10-K · filed 2026-03-02 |
| 2024-09-30 | $49.53M 10-Q · filed 2024-12-26 |
| 2024-06-30 | $245.49M 10-Q/A · filed 2024-12-26 |
| 2024-03-31 | $229.96M 10-Q/A · filed 2024-12-26 |
| 2023-12-31 | $56.37M 10-K · filed 2025-03-17 |
| 2023-09-30 | $130.73M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |